11 Sunscreens Sold In New Zealand Didn't Meet SPF Claims, As Revealed By An Australian Test
Australian consumer group Choice's test of household sunscreens has shown 16 out of 20 tested sunscreens didn't meet their SPF claims.
These include products sold in New Zealand, including Banana Boat, Nivea and Neutrogena sunscreens.
Consumer NZ research and test writer Belinda Castles says consumers expect sunscreens to protect them. But Castles isn't surprised the protection falls short of what's claimed on the bottle.
'Consumer NZ ran a sunscreen testing programme until 2022, and the results found by Choice are consistent with what we've found previously,' she says.
The Choice test found:
Nivea Sun Protect & Moisture Lock SPF50+ tested at SPF40
Sun Bum Premium Moisturising Sunscreen Lotion SPF50+ tested at SPF40.
Consumer's 2021 tests of both these sunscreens also got SPF results in the 40s.
Banana Boat, Bondi Sands and Neutrogena sunscreens also failed to meet their SPF label claims in both Choice and earlier Consumer testing.
While most of the products in the Australian tests still provide moderate or high SPF protection, one product – Ultra Violette Lean Screen SPF50+ Mattifying Zinc Sunscreen – only returned an SPF of 4. Choice tested the sunscreen again at a second lab to confirm this result and got a similar low SPF of5. This sunscreen is also sold in New Zealand.
Castles says the test results for the big sunscreen brands is particularly concerning, given these companies' lack of transparency about when and where their products are tested.
'Sunscreens sold in New Zealand are now regulated under the Sunscreen (Product Safety Standard) Act 2022 and must meet the Australian and New Zealand sunscreen standard, which has requirements for independent testing. However, when we updated our sunscreens database last year, the companies that market Banana Boat, Bondi Sands, Neutrogena, Nivea and Sun Bum refused to provide this information.'
Consumer has also been campaigning for companies to be required to test their sunscreens regularly to ensure the products continue to meet their label claims.
'Our sunscreen research found some companies were relying on test results that are several years old. The latest Choice tests back our call.'
Invisible Zinc Face + Body Mineral Sunscreen SPF50+ tested at 38 in the Australian test. The company told Consumer this product was last tested in 2017.
Woolworths Sunscreen SPF50+ Everyday Lotion tested at 27 in the Australian test. The company told Consumer this product was last tested in 2018.
Choice is calling on Australia's Therapeutic Goods Administration to urgently carry out its own sunscreen compliance testing. Choice has also asked the Australian Competition and Consumer Commission (ACCC) to investigate if any SPF claims are misleading.
Consumer will be raising the same issues with New Zealand regulators and the Commerce Commission.
Products tested available in New Zealand
SPF results in 50+
La Roche-Posay Anthelios Wet Skin Sunscreen SPF 50+ – tested at 72
Neutrogena Ultra Sheer Body Lotion SPF 50 – tested at 56
Mecca Cosmetica To Save Body SPF 50+ Hydrating Sunscreen – tested at 51
SPF results in the 40s
Nivea Sun Kids Ultra Protect and Play Sunscreen Lotion SPF 50+ – tested at 41
Nivea Sun Protect and Moisture Lock SPF 50+ Sunscreen – tested at 40
Sun Bum Premium Moisturising Sunscreen Lotion 50+ – tested at 40
SPF results in the 30s
Banana Boat Sport Sunscreen Lotion SPF 50+ – tested at 35
Bondi Sands SPF 50+ Fragrance Free Sunscreen – tested at 32
Invisible Zinc Face + Body Mineral Sunscreen SPF 50 – tested at 38
SPF results in the 20s
Banana Boat Baby Zinc Sunscreen Lotion SPF 50+ – tested at 28
Bondi Sands SPF 50+ Zinc Mineral Body Lotion – tested at 26
Neutrogena Sheer Zinc Dry-Touch Lotion SPF 50 – tested at 24
Woolworths Sunscreen Everyday Tube SPF 50+ – tested at 27
SPF results <10
Ultra Violette's Lean Screen SPF 50+ Mattifying Zinc Skinscreen – tested at 4
For the full test results, visit CHOICE sunscreen results: https://www.choice.com.au/health-and-body/beauty-and-personal-care/skin-care-and-cosmetics/articles/sunscreen-test
In partnership with Health New Zealand Te Whatu Ora, Consumer NZ's sunscreen database allows users to filter sunscreens by factors such as price, water resistance, SPF protection and the last time a sunscreen was tested.
For more information about sunscreens, including information about the 150+ sunscreens in our database, visit: Sunscreens | Overview - Consumer NZ: https://www.consumer.org.nz/products/sunscreens
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
7 hours ago
- Scoop
Do I Have To Pay For My Partner's Care?
RNZ's money correspondent answers your questions. Send your questions to If one person in a de facto relationship needs permanent medical care, does the Government require the other partner to pay for the care once the unwell patient's funds run out? The basic answer to your question is that when your partner is being assessed for their ability to pay for their care, your income and assets will usually be taken into account. If you're referring to medical care in a rest home setting, your assets and personal income affect whether your partner will qualify for a residential care subsidy. 'People who need residential care are required to pay for it themselves, if they can afford to do so. If they cannot afford it, they may be eligible for a residential care subsidy, which Health New Zealand pays directly to the care provider,' said Ministry of Social Development group general manager for client service delivery Graham Allpress. 'MSD's role is to check whether people qualify for this subsidy by performing a 'financial means assessment'. 'To get the subsidy, a person's income and assets must be under a certain amount. If they are in a relationship, the combined income and assets of both parties must be under a certain amount.' People can qualify for the subsidy if they are 50 to 64, single and without dependent children, or over 65 and meet the income and means test. That means, even if your partner's funds have run out, your assets could still be taken into account. If only one partner needs care, the couple combined need to have assets of no more than $155,873 not including the family home and car, or $284,636 if you do want the home and car in the assessment. If it's other types of care that you're thinking of, it could be a good idea to contact Health NZ for a needs assessment. There are options such as the supported living payment but eligibility for this is assessed on a household income basis, too. I'm currently a NZ tax resident living in NZ, but previously lived in Australia (over a decade ago) and purchased shares on the ASX that I continue to own and receive dividends for (which I declare as part of my income). If I sold these shares now, worth about $150,000, what taxes would they be subject to? Specifically, would I have to pay a capital gains tax on the increased share value (as I would if I were an Australian tax resident). This is probably a question for an accountant with expertise in Australian tax. Based on information available online, it seems that you potentially should have paid tax on the shares in Australia when you stopped being an Australian resident. Assuming that didn't happen, the Australian Tax Office is likely to be expecting capital gains tax to be paid on them when they are sold. You aren't likely to have any New Zealand tax obligations. Tax experts tell me that the authorities have access to a lot of data these days so it's possible that the Australian Tax Office will find out about any share sale and might get in touch with you. I am 78 years of age and still work part time and also still contribute to my KiwiSaver. Am I eligible for the government contribution? Sorry, no. While the government said it was going to start making contributions to 16 and 17-year-olds' accounts, it hasn't budged on the upper limit of 65.
Scoop
11 hours ago
- Scoop
Do I Have To Pay For My Partner's Care?
Send your questions to If one person in a de facto relationship needs permanent medical care, does the Government require the other partner to pay for the care once the unwell patient's funds run out? The basic answer to your question is that when your partner is being assessed for their ability to pay for their care, your income and assets will usually be taken into account. If you're referring to medical care in a rest home setting, your assets and personal income affect whether your partner will qualify for a residential care subsidy. "People who need residential care are required to pay for it themselves, if they can afford to do so. If they cannot afford it, they may be eligible for a residential care subsidy, which Health New Zealand pays directly to the care provider," said Ministry of Social Development group general manager for client service delivery Graham Allpress. "MSD's role is to check whether people qualify for this subsidy by performing a 'financial means assessment'. "To get the subsidy, a person's income and assets must be under a certain amount. If they are in a relationship, the combined income and assets of both parties must be under a certain amount." People can qualify for the subsidy if they are 50 to 64, single and without dependent children, or over 65 and meet the income and means test. That means, even if your partner's funds have run out, your assets could still be taken into account. If only one partner needs care, the couple combined need to have assets of no more than $155,873 not including the family home and car, or $284,636 if you do want the home and car in the assessment. If it's other types of care that you're thinking of, it could be a good idea to contact Health NZ for a needs assessment. There are options such as the supported living payment but eligibility for this is assessed on a household income basis, too. I'm currently a NZ tax resident living in NZ, but previously lived in Australia (over a decade ago) and purchased shares on the ASX that I continue to own and receive dividends for (which I declare as part of my income). If I sold these shares now, worth about $150,000, what taxes would they be subject to? Specifically, would I have to pay a capital gains tax on the increased share value (as I would if I were an Australian tax resident). This is probably a question for an accountant with expertise in Australian tax. Based on information available online, it seems that you potentially should have paid tax on the shares in Australia when you stopped being an Australian resident. Assuming that didn't happen, the Australian Tax Office is likely to be expecting capital gains tax to be paid on them when they are sold. You aren't likely to have any New Zealand tax obligations. Tax experts tell me that the authorities have access to a lot of data these days so it's possible that the Australian Tax Office will find out about any share sale and might get in touch with you. I am 78 years of age and still work part time and also still contribute to my KiwiSaver. Am I eligible for the government contribution? Sorry, no. While the government said it was going to start making contributions to 16 and 17-year-olds' accounts, it hasn't budged on the upper limit of 65.
Scoop
a day ago
- Scoop
St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients
Press Release – Veriphi The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real … St Vincent's Hospital Melbourne has signed a 12-month supply agreement with New Zealand MedTech company Veriphi, to deploy its breakthrough intravenous medication verification technology in the hospital's sterile oncology compounding pharmacy. The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real time. The goal: reduce preventable harm from medication errors and improve dosing accuracy for vulnerable cancer patients. St Vincent's Hospital Melbourne, a tertiary public healthcare provider with more than 880 beds and over 5,000 staff, is part of St Vincent's Health Australia – the country's largest not for-profit health and aged care provider. 'St Vincent's Hospital Melbourne is excited to be working with technology company Veriphi to improve medication safety in our sterile oncology compounding pharmacy,' said Andrew Cording, Chief Pharmacist from St Vincent's. 'The safety of our patients, including medication safety, is a top priority for St Vincent's, so we are proud to be working with world-leading technology.' The agreement reflects a shared commitment to innovation and safety in cancer care, with Veriphi's system designed to support pharmacists and clinical staff in verifying complex, high-risk medications. 'We are delighted to be working with St Vincent's Hospital Melbourne,' said Greg Shanahan, Managing Director of Veriphi. 'Our values regarding the protection of patient safety from medication error align perfectly with St Vincent's. We are proud to collaborate with an organisation whose culture and focus on patient outcomes are supported by Veriphi's breakthrough technology.' Medication errors remain one of the most serious – and preventable – threats to patient safety worldwide. Intravenous drugs, particularly those used in oncology, require precise handling and verification to avoid harm. Veriphi's analyser brings a new layer of safety, enabling hospitals to verify each dose at the point of compounding before administration to patients. The St Vincent's partnership marks a major milestone for Veriphi's commercial rollout, with further expansion plans underway across Australia, New Zealand, and the United States. Veriphi is currently raising funds to expand its impact around the globe. New Zealand and Australian residents can invest at
